|Systematic (IUPAC) name|
|6-allyl-6-nor-lysergic acid diethylamide|
|Legal status||Legal (CA) Legal (UK) Controlled in the United States via the Federal Analog Act (US)|
|(what is this?)|
|This article documents an emerging or novel drug.
A lack of published research means sources may not meet Wikipedia standards. (December 2013)
AL-LAD, also known as 6-allyl-6-nor-LSD, is a novel psychedelic drug and an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL (Tryptamines i Have Known And Loved). While AL-LAD has subtly different effects than LSD, and appears to be slightly shorter lasting, their potencies are similar; an active dose of AL-LAD is reported to be between 80 and 160 micrograms though there are many reports of higher dosages being taken.
AL-LAD does not cause a colour change with the marquis, mecke or mandelin reagents but does cause the ehrlich's reagent to turn purple because of the presence of the indole moiety in its structure.
- Hoffman AJ, Nichols DE (September 1985). "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives". Journal of Medicinal Chemistry 28 (9): 1252–5. doi:10.1021/jm00147a022. PMID 4032428.
- Shulgin, Alexander; Ann Shulgin (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press, 392. ISBN 0-9630096-9-9. OCLC 38503252.
- "AL-LAD Thread. UKChemicalResearch.org".
- Ecstasydata. "EcstasyData.org - AL-LAD (Not sold as ecstasy)". Retrieved 2013-12-25.
|This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it.|